Cyclo Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cyclo Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Cyclo Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 28.7M shares, a 87.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 28.7M +13.4M +87.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 28.6M +18.6M +185% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 28.6M +20.1M +237% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 19.4M +10.9M +129% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 15.3M +6.87M +81.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 10.1M +1.64M +19.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 8.48M +78K +0.93% Dec 31, 2022 10-K 2024-03-18
Q3 2022 8.46M +2M +31% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 8.44M +2M +31.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 8.42M +2.06M +32.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 8.4M +3.63M +76.2% Dec 31, 2021 10-K 2023-03-17
Q3 2021 6.45M -163M -96.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 6.44M -135M -95.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 6.36M -115M -94.8% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 4.77M +3.56M +292% Dec 31, 2020 10-K 2022-03-11
Q3 2020 170M +48.8M +40.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 142M +21.1M +17.5% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 122M +30.8M +33.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 1.22M -89.5M -98.7% Dec 31, 2019 10-K 2021-03-12
Q3 2019 121M +33.9M +38.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 121M +33.3M +38.2% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 90.8M +17.8M +24.3% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 90.8M +17.8M +24.3% Dec 31, 2018 10-K 2020-03-30
Q3 2018 87.2M +14.2M +19.5% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 87.2M +14.4M +19.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 73M +112K +0.15% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 73M +6.05M +9.03% Dec 31, 2017 10-K 2019-03-15
Q3 2017 73M +6.05M +9.03% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 72.9M +6.21M +9.31% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 72.9M +14.2M +24.2% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 67M +8.28M +14.1% Dec 31, 2016 10-K 2018-04-16
Q3 2016 67M +8.28M +14.1% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 66.7M +12.2M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 58.7M +4.21M +7.74% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 58.7M +4.25M +7.81% Dec 31, 2015 10-K 2017-03-17
Q3 2015 58.7M +4.39M +8.09% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 54.5M +2M +3.81% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 54.5M +6M +12.4% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 54.4M +17M +45.3% Dec 31, 2014 10-K 2016-03-30
Q3 2014 54.3M +16.8M +44.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 52.5M +15.6M +42.2% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 48.5M +11.6M +31.4% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 37.5M +566K +1.54% Dec 31, 2013 10-K 2015-03-27
Q3 2013 37.5M +566K +1.54% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 36.9M +314K +0.86% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 36.9M +314K +0.86% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 36.9M +314K +0.86% Dec 31, 2012 10-K 2014-03-04
Q3 2012 36.9M +642K +1.77% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 36.6M +1.06M +2.99% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 36.6M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 36.6M +1.17M +3.29% Dec 31, 2011 10-K 2013-03-14
Q3 2011 36.2M Sep 30, 2011 10-Q/A 2012-02-23
Q2 2011 35.5M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 35.4M Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.